Invasive and minimally invasive treatment modalities for lower urinary tract symptoms: What are the relevant differences in randomised controlled trials?

European Urology

Volumn 38, Issue SUPPL. 1, 2000, Pages 7-17

  Tubaro, Andrea ^a,b   Vicentini, Carlo ^a   Renzetti, Roberto ^a   Miano, Lucio ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Universit a degli Studi dell Aquila   (Italy)

Author keywords

Laser; Open prostatectomy; Prostatic hyperplasia; TUIP; TUMT; TUNA; TURP; TUVP

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; FINASTERIDE;

AGED; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA BASE; HOLMIUM LASER; HUMAN; HYPERTHERMIC THERAPY; INCIDENCE; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; RETROGRADE EJACULATION; RISK FACTOR; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URETHRA DISEASE; URINARY TRACT INFECTION; URINE FLOW RATE; VAPORIZATION; WORLD HEALTH ORGANIZATION;

EID: 0033672891     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052397     Document Type: Conference Paper

References (104)

1. The prevalence of prostatism: A population-based survey of urinary symptoms
2. High prevalence of benign prostatic hypertrophy in the community
3. Management of symptomatic BPH in Italy: Who is treated and how?
4. Combined retropubic prostatectomy and preperitoneal inguinal herniorrhaphy
5. Transurethral resection of the prostate among Medicare beneficiaries in the United States: Time trends and outcomes. Prostate Patient Outcomes Research Team (PORT)
6. The economics of the management of lower urinary tract symptoms and benign prostatic hyperplasia
7. Economic issues and the management of benign prostatic hyperplasia
8. Prostatectomy and sexual function
9. Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients
10. Surgery
11. Uber die Erfolge der Suprapubischen prostatectomie nach eigener methode
12. Transvesical prostatectomy in elderly patients
13. Standard surgical interventions: TUIP/TURP/OPSU
14. Long term results of transurethral and transvesical prostatectomy. A randomized study
15. The long-term effects of prostatectomy: A uroflowmetric analysis
16. Long-term clinical reliability of transurethral and open prostatectomy for benign prostatic obstruction: A term of comparison for nonsurgical procedures
17. Open or transurethral surgery for the large prostate gland
18. Transcervical prostatectomy in perspective
19. The outcome of suprapubic prostatectomy: A contemporary series in the developing world
20. Is open prostatectomy really obsolete?
21. The costs of prostatectomy for benign prostatic hyperplasia
22. Recent developments in the surgical management of benign prostatic hyperplasia
23. Transurethral prostatectomy
24. Clinical evaluation of transurethral versus transvesical prostatectomy. A randomized study
25. The American Urological Association symptom index for benign prostatic hyperplasia
26. 3-year followup of urinary symptoms after transurethral resection of the prostate
27. The efficacy of transurethral resection of the prostate in men with moderate symptoms of prostatism
28. Transurethral microwave thermotherapy versus transurethral resection for benign prostatic hyperplasia: Preliminary results of a randomized study
29. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on transurethral resection of the prostate
30. Symptomatic outcome of transurethral prostatectomy, alpha blockade and placebo in the treatment of benign prostatic hyperplasia. Evaluation of treatment with the Danish Prostatic Symptom Score (DAN-PSS-1) system, The ALFECH study Group
31. Does evaluation with the international prostate symptom score predict the outcome of transurethral resection of the prostate?
32. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives
33. The use of generic measures of health-related quality of life in the assessment of outcome from transurethral resection of the prostate
34. The influence of prostatic anatomy on the differing results of prostatectomy according to the surgical approach
35. Bladder neck incision or transurethral electroresection for treatment of urinary obstruction caused by a small prostate? A randomized urodynamic study
36. Benign prostatic hyperplasia: A population-based study
37. Factors influencing the mortality and morbidity of transurethral prostatectomy
38. Clinical analysis in 2266 cases of transurethral resection of the prostate
39. Transurethral prostatectomy: A long-term follow-up study of 166 patients over 80 years of age
40. The evaluation of transurethral resection for benign enlargement of the prostate
41. Deaths and complications following prostatectomy in 1400 men in the northern region of England. Northern Regional Prostate Audit Group
42. Urethral strictures following transurethral prostatectomy: A review of 2,223 resections
43. Factors affecting change in quality of life after prostatectomy for benign prostatic hypertrophy: The impact of surgical techniques
44. Potency and prostatectomy
45. Post-prostatectomy impotence
46. Sexual life following 'minimal' and 'total' transurethral prostatic resection
47. Seksuel potens of prostataoperation
48. Erectile impotence associated with transurethral prostatectomy
49. Transurethral incision of the prostate
50. Transurethral incision of the prostate
51. Transurethral incision of the prostate and bladder neck
52. Transurethral prostatectomy or incision of the prostate in the treatment of prostatism caused by small benign prostate
53. Transurethral incision of prostate compared with transurethral resection of prostate in 132 matching cases
54. Transurethral incision of the bladder neck and prostate
55. Transurethral incision of the prostate: An objective and subjective evaluation of long-term efficacy
56. Outcome analysis of minimally invasive treatments for benign prostatic hyperplasia
57. Transurethral electrovaporization of the prostate vs. transurethral resection. Results of a multicentric, randomized clinical study on 150 patients
58. Transurethral electrovaporization of the prostate - A possible alternative to transurethral resection: A one-year follow-up of a prospective randomized trial
59. A randomized study comparing visual laser ablation and transurethral evaporation of prostate in the management of benign prostatic hyperplasia
60. Transurethral prostatectomy: A prospective randomized study of conventional resection and electrovaporization in benign prostatic hyperplasia
61. A prospective randomized study of transurethral resection of the prostate and transurethral vaporization of the prostate as a therapeutic alternative in the management of men with BPH
62. Transurethral vaporisation of the prostate: A promising new technique
63. A comparative study of laser ablation and transurethral electroresection for benign prostatic hyperplasia: Results of a 6-month follow-up
64. Transurethral resection of the prostate versus transurethral electrovaporization of the prostate: A blinded, prospective comparative study with 1-year follow-up
65. Neodymium:yttrium-aluminum-garnet laser prostatectomy
66. A critical evaluation of technological innovations in the treatment of symptomatic benign prostatic hyperplasia
67. A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate
68. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia
69. Comparative study of laser versus electrocautery prostatic resection: 18-month followup with complex urodynamic assessment
70. A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia
71. Holmium laser resection of the prostate versus neodymium:yt-trium-aluminum-garnet visual laser ablation of the prostate: A randomized prospective comparison of two techniques for laser prostatectomy
72. Transurethral interstitial laser coagulation for benign prostatic hyperplasia: Treatment outcome and quality of life
73. Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia
74. Interstitial laser therapy
75. Neodynium YAG laser treatment of BPH using interstitial thermotherapy: A transurethral approach
76. A randomized prospective study of transurethral electrovaporization vs laser ablation of the prostate in men with benign prostatic hypertrophy
77. Interstitial laser therapy of benign prostatic hyperplasia
78. The Oxford Laser Prostate Trial: A double-blind randomized controlled trial of contact vaporization of the prostate against transurethral resection; preliminary results
79. A double-blind randomized controlled trial and economic evaluation of transurethral resection versus contact laser vaporization for benign prostatic enlargement: A 3-year follow-up
80. Long-term follow-up of contact laser prostatectomy
81. Holmium laser versus transurethral resection of the prostate: A randomized prospective trial with 1-year followup
82. Single-session transurethral microwave thermotherapy for the treatment of benign prostatic obstruction
83. Transurethral microwave heating of the prostate - Or from hyperthermia to thermotherapy
84. High energy thermotherapy versus transurethral resection in the treatment of benign prostatic hyperplasia: Results of a prospective randomized study with 1 year of follow up
85. Neoadjuvant and adjuvant alpha-blockade improves early results of high energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyper-plasia: A randomised, prospective clinical trial
86. A randomized controlled trial of transurethral microwave thermotherapy
87. Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction
88. Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: Results of a randomized, double-blind, multicenter, sham-controlled trial
89. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia
90. Transurethral needle ablation (TUNA)
91. Outcome of prostatectomy
92. Transurethral electrovaporization of the prostate: A novel method for treating men with benign prostatic hyperplasia
93. Holmium laser resection of the prostate: Preliminary results of a new method for the treatment of benign prostatic hyperplasia
94. Prostate heating patterns comparing elec-trosurgical transurethral resection and vaporization: A prospective randomized study
95. This month in investigative urology: Transurethral laser treatment of benign prostatic hyperplasia
96. A randomised single institution study comparing laser prostatectomy and transurethral resection of the prostate
97. Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: Long-term results
98. Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: Early clinical experience
99. Two-year results of transurethral resection of the prostate versus four 'less invasive' treatment options
100. Is transurethral resection of the prostate still justified?
101. BPH: Clinical Research Criteria